Ownership history in Murchinson Ltd. · 4 quarters on record
This page tracks every 13F SEC filing in which Murchinson Ltd. reported a position in ARBUTUS BIOPHARMA CORP (ABUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 222,900 | -52,100 | -18.9% | 0.17% | $1.1M | $4.81 |
| 2025 Q4 | ADDED | 275,000 | +75,000 | +37.5% | 0.21% | $1.3M | $4.81 |
| 2025 Q3 | REDUCED | 200,000 | -22,900 | -10.3% | 0.12% | $908K | $4.54 |
| 2025 Q3 | INITIATED | 222,900 | — | — | 0.13% | $1.0M | $4.54 |
As of 2025 Q4 — sorted by position size